Heather A. Boux
10Patents
7h-index
8Co-inventors
55Inventor score
Filing activity: Nov 23, 1988 → Oct 3, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5085862A | Genetic detoxification of pertussis toxin | Emerging Cross-Sectional Technologies | 54 | Expired |
| US5358868A | Genetic detoxification of pertussis toxin | Human Necessities | 31 | Expired |
| US5221618A | Genetic detoxification of pertussis toxin | Human Necessities | 19 | Expired |
| US5244657A | Genetic detoxification of pertussis toxin | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5433945A | Immunoprotective genetically-detoxified mutants of pertussis toxin | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5332583A | Vaccine containing genetically-detoxified pertussis holotoxin | Human Necessities | 15 | Expired |
| US7326574B2 | Compositions and methods for detecting stress-inducible proteins | Human Necessities | 14 | Active |
| US6964851B2 | Compositions and methods for detecting stress-inducible proteins | Human Necessities | 5 | Expired |
| US7105161B1 | Proteinaceous adjuvants | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7138247B2 | Compositions and methods for detecting stress-inducible proteins | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.